Abstract
This article completes a summary of the common medical emergencies that can occur as a result of infectious processes (Part I) and antitumor treatment secondary to chemotherapy, biological response modifiers, or radiotherapy (Part II). The use of high-dose cytotoxic agents, coupled with the common instillation of indwelling central venous access devices, have altered the spectrum of infectious etiologies that are appreciated in clinical practice. In addition, a myriad of cytotoxic agents and radiotherapeutic treatment schemes are used widely in clinical oncologic practice. While most of their related side effects are not considered life-threatening emergencies, they can be fatal if not recognized early and treated promptly. Moreover, some of these infectious and treatment-related sequelae can be prevented. This article highlights some of these clinical observations.
Original language | English (US) |
---|---|
Pages (from-to) | 839-852 |
Number of pages | 14 |
Journal | Journal of the National Medical Association |
Volume | 86 |
Issue number | 11 |
State | Published - Nov 1994 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)